[Home](https://github.com/mm80843/T3.5/blob/pages/index.md) >> Class: [Stakeholder](https://github.com/mm80843/T3.5/tree/main/docs/Stakeholder/index.md) >> Individual ID:PBN__Stakeholder_46 

# __Scientists__

## 5. Blueprint mitigation can be owned by these stakeholders

* [Implementing Innovative Techniques to Thwart Contagious Disease Spread](https://github.com/mm80843/T3.5/blob/pages/aBlueprint/PBN__aBlueprint_0.md)
* [Implementing Regular Cleaning, WBE and Quarantine Measures for Infectious Diseases Mitigation](https://github.com/mm80843/T3.5/blob/pages/aBlueprint/PBN__aBlueprint_37.md)

## Category to which it belongs

* [A diverse range of individuals and groups involved in various fields, research, projects, media, teams, and organizations.](https://github.com/mm80843/T3.5/blob/pages/PBNCategory/PBN__PBNCategory_241.md)

## Closest similar item

* [Environmental scientist](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_1840.md)
* [Environmental scientists](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_137.md)
* [Laboratory researchers](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_355.md)
* [Medical researchers](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_2591.md)
* [Researchers](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_2.md)
* [Scientific community](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_2585.md)
* [Scientific research](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_1817.md)
* [Scientist](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_1557.md)
* [Scientists and researchers](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_348.md)
* [Scientists/researchers](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_685.md)

## Risk affecting this stakeholder

* [Cell entry of sars-cov-2](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_1243.md)
* [Confounding variables](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_2151.md)
* [Contextual factors](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_1443.md)
* [Disintegrated and non-interoperable data](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_1439.md)
* [Effects of nebulization and impingement on viral survival](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_1441.md)
* [Incomplete coverage of information in ontologies](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_762.md)
* [Insufficient knowledge of covid-19 inactivation mechanisms on copper coatings](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_1442.md)
* [Lack of bioinformatics tools](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_1440.md)
* [Lack of control of environmental conditions](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_615.md)
* [Lack of ontology interoperability](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_1484.md)
* [Lack of real-time data](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_1376.md)
* [Loss of monitoring and research activities](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_1375.md)
* [Loss of validity](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_2333.md)
* [Poor solubility and processing of graphene materials](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_2275.md)
* [Rapidly changing understanding of covid-19](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_1378.md)
* [Relationship between ah, rh, and temperature](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_1126.md)
* [Spread of fraudulent studies](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_1692.md)

## Risks that can be mitigated by this stakeholder

* [Cell entry of sars-cov-2](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_642.md)
* [Complex wastewater matrix as a challenge for biosensor detection](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_1144.md)
* [Complexity of wastewater matrix](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_431.md)
* [Development of drugs](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_1145.md)
* [Discrepancies in pcr results among laboratories](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_430.md)
* [Effect of rh on uv susceptibility](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_338.md)
* [Effects of nebulization and impingement on viral survival](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_2335.md)
* [Expectations for vaccine](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_1148.md)
* [Inefficient voc removal by plants](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_1146.md)
* [Key factors of covid-19 transmission](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_2336.md)
* [Knowledge gaps and future threats](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_1147.md)
* [Lack of effective disinfectants](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_1125.md)
* [Lack of specific biomarkers for covid-19 detection in wastewater](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_634.md)
* [Limited accuracy and specificity of biomarker measurements](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_2276.md)
* [Limited availability of biosensors for wastewater analysis](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_2274.md)
* [Limited sensitivity and accuracy of pcr methods](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_2333.md)
* [Need for alternative detection methods](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_2332.md)
* [Need for concentration methods](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_2334.md)
* [Need for standardization and validation of analytical protocols](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_1142.md)
* [Poor solubility and processing of graphene materials](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_1141.md)
* [Spread of sars-cov-2](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_1149.md)
* [Tissue tropism and pathogenesis of sars-cov-2](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_2275.md)
* [Toxicity of nanomaterials](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_2280.md)
* [Unclear origin of sars-cov-2](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_1143.md)
* [Uv dosage levels required under different conditions](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_1126.md)
* [Uv susceptibility of viral aerosols](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_1127.md)

## These stakeholders can be supported by the following general blueprint

* [Implementing Cybersecurity and Transparency Strategies to Mitigate Contagious Disease Spread](https://github.com/mm80843/T3.5/blob/pages/aBlueprint/PBN__aBlueprint_28.md)
* [Implementing Real-time Epidemiological Data Collection and Analysis to Mitigate Virus Spread](https://github.com/mm80843/T3.5/blob/pages/aBlueprint/PBN__aBlueprint_36.md)

## This Stakeholder belongs to this StakeholderGroup

* [Health authorities](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_394.md)

## This Stakeholder belongs to this StakeholderSubgroup

* [Scientific research](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_1817.md)

## This Stakeholder can get these Benefits from mitigation measures

* [Access to real-time data](https://github.com/mm80843/T3.5/blob/pages/Benef/PBN__Benef_60.md)
* [Data analysis efficiency](https://github.com/mm80843/T3.5/blob/pages/Benef/PBN__Benef_63.md)
* [Data integration](https://github.com/mm80843/T3.5/blob/pages/Benef/PBN__Benef_61.md)
* [Data sharing and integration](https://github.com/mm80843/T3.5/blob/pages/Benef/PBN__Benef_62.md)
* [Enhanced credibility and reputation](https://github.com/mm80843/T3.5/blob/pages/Benef/PBN__Benef_64.md)
* [Knowledge sharing and research development](https://github.com/mm80843/T3.5/blob/pages/Benef/PBN__Benef_65.md)
* [Standardized knowledge representation](https://github.com/mm80843/T3.5/blob/pages/Benef/PBN__Benef_1018.md)
* [Thorough study of anti-coronavirus drugs](https://github.com/mm80843/T3.5/blob/pages/Benef/PBN__Benef_1016.md)
* [Vaccine design and analysis](https://github.com/mm80843/T3.5/blob/pages/Benef/PBN__Benef_1046.md)

## Type of the stakeholder

* [At risk](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_Type_0.md)
* [Beneficiary](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_Type_2.md)
* [Risk owner](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_Type_1.md)

